Please login to the form below

Not currently logged in
Email:
Password:

Medicines for Europe

This page shows the latest Medicines for Europe news and features for those working in and with pharma, biotech and healthcare.

Nordic Capital acquires ADVANZ PHARMA for $846m

Nordic Capital acquires ADVANZ PHARMA for $846m

UK-based ADVANZ PHARMA has a strategic focus on complex medicines in Europe, with expertise in anti-infectives and endocrinology therapy areas. ... This deal is fantastic news for ADVANZ PHARMA and our goal of becoming the go-to partner for complex

Latest news

More from news
Approximately 1 fully matching, plus 32 partially matching documents found.

Latest Intelligence

  • The sound of silence puts the squeeze on generics and biosimilars The sound of silence puts the squeeze on generics and biosimilars

    Medicines for Europe vows to get  governments talking to realise potential. The future of generics and biosimilars is something to shout about but the sector fears the mute button has been ... Medicines for Europe is also trying to soften the

  • Interview: Cesar Rodriguez, Janssen Interview: Cesar Rodriguez, Janssen

    We cannot forget the fact that the UK has already among the lowest prices for medicines in Europe, and this is something that everybody should know. ... But this is not happening in all cases. “We still have one of the lowest rates of uptake for new

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • EFPIA confirms first and second vice-presidents EFPIA confirms first and second vice-presidents

    That includes working with governments to reduce access delays and improve the availability of medicines for patients across Europe.  I look forward to working with the EFPIA Board and the wider ... Meanwhile, Laureau said: “Recent events have

  • Pfizer's Andrew Thomas takes up UK comms agency role

    Prior to joining the Creston Health Group agency he served at Pfizer as strategic communications lead for primary care medicines across Europe and Canada. ... During this time, he handled a portfolio that included many of the company's highest profile

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
McCann Health Medical Communications

We are the medical communications experts within McCann Health. Communicating science to bring meaning and positive change to people’s lives....

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...